Cargando…

Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients

BACKGROUND: Bronchoalveolar lavage (BAL) is a major diagnostic tool in interstitial lung disease (ILD). Its use remains largely quantitative, usually focused on cell differential ratio. However, cellular morphological features provide additional valuable information. The significance of the “immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Moui, Antoine, Dirou, Stéphanie, Sagan, Christine, Liberge, Renan, Defrance, Claire, Arrigoni, Pierre-Paul, Morla, Olivier, Kandel-Aznar, Christine, Cellerin, Laurent, Cavailles, Arnaud, Eschapasse, Emmanuel, Morio, Florent, Gourraud, Pierre-Antoine, Goronflot, Thomas, Tissot, Adrien, Blanc, François-Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897721/
https://www.ncbi.nlm.nih.gov/pubmed/35247991
http://dx.doi.org/10.1186/s12890-022-01871-w
_version_ 1784663490609283072
author Moui, Antoine
Dirou, Stéphanie
Sagan, Christine
Liberge, Renan
Defrance, Claire
Arrigoni, Pierre-Paul
Morla, Olivier
Kandel-Aznar, Christine
Cellerin, Laurent
Cavailles, Arnaud
Eschapasse, Emmanuel
Morio, Florent
Gourraud, Pierre-Antoine
Goronflot, Thomas
Tissot, Adrien
Blanc, François-Xavier
author_facet Moui, Antoine
Dirou, Stéphanie
Sagan, Christine
Liberge, Renan
Defrance, Claire
Arrigoni, Pierre-Paul
Morla, Olivier
Kandel-Aznar, Christine
Cellerin, Laurent
Cavailles, Arnaud
Eschapasse, Emmanuel
Morio, Florent
Gourraud, Pierre-Antoine
Goronflot, Thomas
Tissot, Adrien
Blanc, François-Xavier
author_sort Moui, Antoine
collection PubMed
description BACKGROUND: Bronchoalveolar lavage (BAL) is a major diagnostic tool in interstitial lung disease (ILD). Its use remains largely quantitative, usually focused on cell differential ratio. However, cellular morphological features provide additional valuable information. The significance of the “immune alveolitis” cytological profile, characterized by lymphocytic alveolitis with activated lymphocytes and macrophages in epithelioid transformation or foamy macrophages desquamating in cohesive clusters with lymphocytes, remains unknown in ILD. Our objective was to describe patients’ characteristics and diagnoses associated with an immune alveolitis profile in undiagnosed ILD. METHODS: We performed a monocentric retrospective observational study. Eligible patients were adults undergoing diagnostic exploration for ILD and whose BAL fluid displayed an immune alveolitis profile. For each patient, we collected clinical, radiological and biological findings as well as the final etiology of ILD. RESULTS: Between January 2012 and December 2018, 249 patients were included. Mean age was 57 ± 16 years, 140 patients (56%) were men, and 65% of patients were immunocompromised. The main etiological diagnosis was Pneumocystis pneumonia (PCP) (24%), followed by drug-induced lung disease (DILD) (20%), viral pneumonia (14%) and hypersensitivity pneumonitis (HP) (10%). All PCP were diagnosed in immunocompromised patients while HP was found in only 8% of this subgroup. DILD and viral pneumonia were also commonly diagnosed in immunocompromised patients (94% and 80%, respectively). CONCLUSION: Our study highlights the additional value of BAL qualitative description in ILD. We suggest incorporating the immune alveolitis profile for the diagnosis and management of ILD, especially in immunocompromised patients, since it guides towards specific diagnoses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-022-01871-w.
format Online
Article
Text
id pubmed-8897721
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88977212022-03-07 Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients Moui, Antoine Dirou, Stéphanie Sagan, Christine Liberge, Renan Defrance, Claire Arrigoni, Pierre-Paul Morla, Olivier Kandel-Aznar, Christine Cellerin, Laurent Cavailles, Arnaud Eschapasse, Emmanuel Morio, Florent Gourraud, Pierre-Antoine Goronflot, Thomas Tissot, Adrien Blanc, François-Xavier BMC Pulm Med Research Article BACKGROUND: Bronchoalveolar lavage (BAL) is a major diagnostic tool in interstitial lung disease (ILD). Its use remains largely quantitative, usually focused on cell differential ratio. However, cellular morphological features provide additional valuable information. The significance of the “immune alveolitis” cytological profile, characterized by lymphocytic alveolitis with activated lymphocytes and macrophages in epithelioid transformation or foamy macrophages desquamating in cohesive clusters with lymphocytes, remains unknown in ILD. Our objective was to describe patients’ characteristics and diagnoses associated with an immune alveolitis profile in undiagnosed ILD. METHODS: We performed a monocentric retrospective observational study. Eligible patients were adults undergoing diagnostic exploration for ILD and whose BAL fluid displayed an immune alveolitis profile. For each patient, we collected clinical, radiological and biological findings as well as the final etiology of ILD. RESULTS: Between January 2012 and December 2018, 249 patients were included. Mean age was 57 ± 16 years, 140 patients (56%) were men, and 65% of patients were immunocompromised. The main etiological diagnosis was Pneumocystis pneumonia (PCP) (24%), followed by drug-induced lung disease (DILD) (20%), viral pneumonia (14%) and hypersensitivity pneumonitis (HP) (10%). All PCP were diagnosed in immunocompromised patients while HP was found in only 8% of this subgroup. DILD and viral pneumonia were also commonly diagnosed in immunocompromised patients (94% and 80%, respectively). CONCLUSION: Our study highlights the additional value of BAL qualitative description in ILD. We suggest incorporating the immune alveolitis profile for the diagnosis and management of ILD, especially in immunocompromised patients, since it guides towards specific diagnoses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-022-01871-w. BioMed Central 2022-03-05 /pmc/articles/PMC8897721/ /pubmed/35247991 http://dx.doi.org/10.1186/s12890-022-01871-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Moui, Antoine
Dirou, Stéphanie
Sagan, Christine
Liberge, Renan
Defrance, Claire
Arrigoni, Pierre-Paul
Morla, Olivier
Kandel-Aznar, Christine
Cellerin, Laurent
Cavailles, Arnaud
Eschapasse, Emmanuel
Morio, Florent
Gourraud, Pierre-Antoine
Goronflot, Thomas
Tissot, Adrien
Blanc, François-Xavier
Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients
title Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients
title_full Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients
title_fullStr Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients
title_full_unstemmed Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients
title_short Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients
title_sort immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897721/
https://www.ncbi.nlm.nih.gov/pubmed/35247991
http://dx.doi.org/10.1186/s12890-022-01871-w
work_keys_str_mv AT mouiantoine immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT diroustephanie immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT saganchristine immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT libergerenan immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT defranceclaire immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT arrigonipierrepaul immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT morlaolivier immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT kandelaznarchristine immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT cellerinlaurent immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT cavaillesarnaud immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT eschapasseemmanuel immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT morioflorent immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT gourraudpierreantoine immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT goronflotthomas immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT tissotadrien immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients
AT blancfrancoisxavier immunealveolitisininterstitiallungdiseaseanattractivecytologicalprofileinimmunocompromisedpatients